SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Centocor ( CNTO ) -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (844)11/23/1998 1:55:00 PM
From: FNS  Respond to of 965
 
Thanks for your input, Henry and Alfredo! I think your right...not a pill but powder...Alfredo also provided pertinent info!

I'm still out...little concerned that 45 was broken but, on the positive side, 43 held and positive trend is still in tact. Actually, according to TA (IMO), the stock could still dip down to 39-40 and still be in uptrend. Therefore, am waiting patiently for still more pullback to dive in.

FNS



To: Henry Niman who wrote (844)11/24/1998 2:04:00 AM
From: David S.  Respond to of 965
 
pill form, infusion...just dessicate the crap and snort it - it'll have the same effect.



To: Henry Niman who wrote (844)11/24/1998 9:25:00 AM
From: Steve Fujikawa  Read Replies (1) | Respond to of 965
 
Henry, so let me get this straight. The potential allergic reaction is confined to those 40 patients who took the original liquid formulation years ago, and will not recur (has not been observed) in those treated with the powder form? What is the difference between the two formulations that causes differing tolerance, are they identical chemically and is it only the fact that one is liquid and the other is solid?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News